Stay updated on PERSEUS1: Pembrolizumab in Advanced Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the PERSEUS1: Pembrolizumab in Advanced Prostate Cancer Clinical Trial page.

Latest updates to the PERSEUS1: Pembrolizumab in Advanced Prostate Cancer Clinical Trial page
- Check3 days agoChange DetectedThe study record page now shows a 403 Forbidden error, indicating the page is currently inaccessible. This replaces the usual study details with an access-restriction message.SummaryDifference20%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6, signaling a new release of the page template. No public content changes are indicated by the provided data.SummaryDifference0.1%

- Check31 days agoChange DetectedFunding information was added to the study record, noting an NIH grant/contract in the 'Other Study ID Numbers' section. This provides context about the financial support behind the trial.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, indicating a newer build of the page. This reflects internal maintenance rather than changes to trial details or text visible to users.SummaryDifference0.1%

- Check60 days agoChange DetectedNew site revision v3.6.4 has been added, replacing v3.6.3. This update appears to be a maintenance version change and does not affect the study content or page operations.SummaryDifference0.1%

- Check81 days agoChange DetectedA minor revision tag was updated from v3.6.2 to v3.6.3. This appears to reflect a small page template or metadata update rather than changes to study content.SummaryDifference0.1%

Stay in the know with updates to PERSEUS1: Pembrolizumab in Advanced Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PERSEUS1: Pembrolizumab in Advanced Prostate Cancer Clinical Trial page.